These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 14521403

  • 1. Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
    Varady J, Wu X, Fang X, Min J, Hu Z, Levant B, Wang S.
    J Med Chem; 2003 Oct 09; 46(21):4377-92. PubMed ID: 14521403
    [Abstract] [Full Text] [Related]

  • 2. Computational elucidation of the structural basis of ligand binding to the dopamine 3 receptor through docking and homology modeling.
    Hobrath JV, Wang S.
    J Med Chem; 2006 Jul 27; 49(15):4470-6. PubMed ID: 16854052
    [Abstract] [Full Text] [Related]

  • 3. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C, Bernard P, Hibert M, Rognan D.
    Proteins; 2003 Jan 01; 50(1):5-25. PubMed ID: 12471595
    [Abstract] [Full Text] [Related]

  • 4. Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists.
    Duan X, Zhang X, Xu B, Wang F, Lei M.
    Chem Biol Drug Des; 2016 Jul 01; 88(1):142-54. PubMed ID: 26851125
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands.
    Zhou B, Hong KH, Ji M, Cai J.
    Chem Biol Drug Des; 2018 Sep 01; 92(3):1597-1609. PubMed ID: 29710404
    [Abstract] [Full Text] [Related]

  • 6. Computational modeling toward understanding agonist binding on dopamine 3.
    Zhao Y, Lu X, Yang CY, Huang Z, Fu W, Hou T, Zhang J.
    J Chem Inf Model; 2010 Sep 27; 50(9):1633-43. PubMed ID: 20695484
    [Abstract] [Full Text] [Related]

  • 7. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE, Tseng T, Brusniak MY, Ginsburg B, Pearlman RS, Teeter M, DuRand C, Starr S, Neve KA.
    J Med Chem; 1998 Oct 22; 41(22):4385-99. PubMed ID: 9784114
    [Abstract] [Full Text] [Related]

  • 8. Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes.
    Boeckler F, Lanig H, Gmeiner P.
    J Med Chem; 2005 Feb 10; 48(3):694-709. PubMed ID: 15689154
    [Abstract] [Full Text] [Related]

  • 9. Molecular modeling of the 3D structure of 5-HT(1A)R: discovery of novel 5-HT(1A)R agonists via dynamic pharmacophore-based virtual screening.
    Xu L, Zhou S, Yu K, Gao B, Jiang H, Zhen X, Fu W.
    J Chem Inf Model; 2013 Dec 23; 53(12):3202-11. PubMed ID: 24245825
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and evaluation of indolebutylamines as a novel class of selective dopamine D3 receptor ligands.
    Du P, Xu L, Huang J, Yu K, Zhao R, Gao B, Jiang H, Zhao W, Zhen X, Fu W.
    Chem Biol Drug Des; 2013 Sep 23; 82(3):326-35. PubMed ID: 23663349
    [Abstract] [Full Text] [Related]

  • 11. Exploring the structural basis and atomistic binding mechanistic of the selective antagonist blockade at D3 dopamine receptor over D2 dopamine receptor.
    Appiah-Kubi P, Olotu FA, Soliman MES.
    J Mol Recognit; 2021 May 23; 34(5):e2885. PubMed ID: 33401335
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D3 receptor ligands with antagonist properties.
    Hackling AE, Stark H.
    Chembiochem; 2002 Oct 04; 3(10):946-61. PubMed ID: 12362359
    [Abstract] [Full Text] [Related]

  • 13. Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.
    Elsner J, Boeckler F, Heinemann FW, Hübner H, Gmeiner P.
    J Med Chem; 2005 Sep 08; 48(18):5771-9. PubMed ID: 16134944
    [Abstract] [Full Text] [Related]

  • 14. Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
    Salama I, Hocke C, Utz W, Prante O, Boeckler F, Hübner H, Kuwert T, Gmeiner P.
    J Med Chem; 2007 Feb 08; 50(3):489-500. PubMed ID: 17266201
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G, Butini S, Trotta F, Fattorusso C, Catalanotti B, Aiello F, Gemma S, Nacci V, Novellino E, Stark JA, Cagnotto A, Fumagalli E, Carnovali F, Cervo L, Mennini T.
    J Med Chem; 2003 Aug 28; 46(18):3822-39. PubMed ID: 12930145
    [Abstract] [Full Text] [Related]

  • 16. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
    Malmberg A, Nordvall G, Johansson AM, Mohell N, Hacksell U.
    Mol Pharmacol; 1994 Aug 28; 46(2):299-312. PubMed ID: 8078492
    [Abstract] [Full Text] [Related]

  • 17. Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation.
    Platania CB, Salomone S, Leggio GM, Drago F, Bucolo C.
    PLoS One; 2012 Aug 28; 7(9):e44316. PubMed ID: 22970199
    [Abstract] [Full Text] [Related]

  • 18. Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors.
    Duan X, Zhang M, Zhang X, Wang F, Lei M.
    J Mol Graph Model; 2015 Apr 28; 57():143-55. PubMed ID: 25728902
    [Abstract] [Full Text] [Related]

  • 19. Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics.
    Kaczor AA, Silva AG, Loza MI, Kolb P, Castro M, Poso A.
    ChemMedChem; 2016 Apr 05; 11(7):718-29. PubMed ID: 26990027
    [Abstract] [Full Text] [Related]

  • 20. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH.
    J Med Chem; 2005 Feb 10; 48(3):839-48. PubMed ID: 15689168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.